Brain oxygen monitor shows promise in protecting preterm infants from injury
NCT ID NCT06729398
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether using a brain oxygen monitor (cerebral NIRS) along with a treatment guideline could prevent brain injury in very low birth weight preterm infants. 129 babies born at 32 weeks or earlier or weighing under 1500 grams took part. The monitor was placed on the baby's head for the first 72 hours of life, and doctors followed a guideline to keep oxygen levels normal. The goal was to see if this approach reduced brain bleeding or white matter damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Near Infrared Spectroscopy (NIRS) device and SafeboosC treatment guideline
What this could lead to
If effective, this monitoring approach could help prevent brain injury and reduce mortality in fragile preterm infants.
What could go wrong
This is a single completed trial with 129 participants, so results may not apply broadly. The device only monitors oxygen levels and does not directly treat injury.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL MORTALITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dr. Cipto Mangunkusumo General Hospital
Jakarta, Indonesia